NEOGEN CORP
NEOG · In Vitro and in Vivo Diagnostic Substances
Latest available SEC filing: 3 ·
Latest disclosures
-
Walter James A: Form 3
Insider disclosure · Filed · Report period 01 Oct 2026
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- NEOG · 640491106 - Common
Company details and SEC sources
CIK 0000711377 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- NEOG on Nasdaq
- SEC industry group
- In Vitro and in Vivo Diagnostic Substances (Office of Life Sciences)
- Business address
- 620 Lesher Place, Lansing, MI, 48912
- Incorporated in
- MI
- Fiscal year end
- 31 May
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields